1 of 6 CCF RESEARCH GRANT APPLICATION 2013 GUIDELINES ...

2. Focus and Innovativeness: the study's focus on understanding the genetic basis/causes of
cardiomyopathy and its relationship to disease progression in children. Also the study's
uniqueness and possibility of breakthrough findings.
3. Feasibility: quality of the science and qualifications of the investigator to carry out the
proposed work, based on expertise, commitment and the availability of all the elements
required for the project (laboratory, technology, reagents and human or animal subjects).
4. Prospect of long term funding: likelihood of subsequent NIH or other major funding to
sustain the project or for any potential follow-up work
All applications will be held in the strictest confidence and all decisions by CCF are final.
III. Terms of the Award
1. Grant Period: One year funding period begins from the time of the award until the same time
the following year (i.e. February 1, 2014 – February 1, 2015). Extensions will be considered
if there is a valid reason for delays in the study.
2. Grant Payment: Upon signing a letter of agreement, CCF will award 50% of the grant award
amount as start up funds. The remaining payments will be based upon meeting certain
milestones and deliverables. An additional 25% of the grant award amount is provided upon
submission of a detailed mid-year progress report.
For studies that involve patient recruitment or acquisition of tissue/blood samples, additional
payments will be contingent on the number of patients enrolled or samples acquired during
the study period. Final payment is dependant on achieving the outlined aims in the proposed
research study, submission of a detailed final report and verification that research findings
will be presented at a recognized medical conference and/or a manuscript has been
submitted/accepted for publication in a peer reviewed medical/scientific journal.
3. Site of Project: Awards can be made to public or private universities, hospitals and
biomedical research institutions in the United States or Canada. The research shall take place
only in the research facility specified in the submitted research proposal. In the event the
primary investigator (PI) leaves his/her affiliated institution, the PI shall make necessary
arrangements with their institution to permit transfer of research funds.
4. Changes of Status of Principal Investigator (PI): The PI shall give the Foundation immediate
written notice if there is any change or potential change in the PI's affiliated institution. Upon
such notice and approval from CCF, the PI shall make arrangements to have the awarded
funds transferred to the new institution the PI is affiliated with. If the PI ceases research in
the field for which the grant was made, CCF will request the return of the unexpended grant
funds.
5. Expenditures: The grant is made only for the purposes stated in the research proposal and
according the proposed research budget. The grant funds, as well as any interest earned
thereon, may not be expended for any other purpose without CCF's prior written approval.
Any funds not expended or committed for the purpose of the grant shall be promptly returned
to the Foundation. The grant is to cover direct costs only and funds may not be used for any
of the following items: institutional overhead, construction or renovation, purchase of major
capital equipment, office equipment or furniture, travel (unless related to research study),
2 of 6